Silent Theatre presentations

Programme stream(s): Silent theatre
Programme session type(s): No session type

18/01/2019 19:40-18/01/2019 21:00

Room: Silent theatre 2 - Hall 4

These theatres provide an area for accepted abstract submitters to present their research in 5 minute presentations.

The abstract presentations in this session are:

19.40 – Natalie Cook, Carcinoma of unknown primary: Diagnosis, treatment and outcomes in a tertiary cancer centre

19.46 – Lyn Jones, Comparison of performance of mammogram readers with breast MRI readers at an abbreviated breast MRI interpretation task: Results from a single centre multireader study using an enhanced data-set

19.52 – Mohanarangam Thangavelu, Role of staging bone scans in the patients with newly diagnosed prostate cancer. Are the current guidelines acceptable?

19.58 – Daniel Ball, T-stage migration by routine pre-biopsy MRI staging may affect risk assessment with current risk classification systems

20.04 – Hester Franks, Adenosine polarises human macrophages towards an immunosuppressive phenotype via the A2A and A2B adenosine receptors

20.10 – Qiuyu Wang, Anticancer activity of arabinoxylan on human gastric adenocarcinoma cells in vitro

20.16 – Robin Grant, Seizure Prophylaxis in Glioma (SPRING): A phase III randomised trial comparing prophylactic Levetiracetam versus no prophylactic anti-epileptic drug in newly diagnosed presumed supratentorial glioma.

20.22 – Kate Butcher, Development of nano-enabled disulfiram reverses pan-chemoresistance by inhibiting hypoxia induced cancer stem cells in non-small cell lung cancer

20.28 – Helen Ross-Adams, PIXdb: Exploring the transcriptomic landscape of prostate cancer development and progression

20.34 – Na Hyun Kim, Propensity Score-Matched Comparison of Focal High Intensity Focused Ultrasound (HIFU) to Laparoscopic Radical Prostatectomy (LRP) for Clinically Significant Localised Prostate Cancer

20.40 – Peter Coussons, Differential redistribution of transglutaminase isoforms in cisplatin resistant hepatocarcinoma (HEPG2) cells

20.46 – Surbhi Kaul, SMC1A: a novel candidate DNA damage biomarker in hair follicles

20.52 – Fiona Blows, Investigation of transglutaminase 2 as a biomarker of invasive breast cancer that is likely to metastasise